Geron, Exeter Affiliates Merge to Create Livestock Cloning Shop
By GenomeWeb,
GenomeWeb
| 08. 12. 2008
NEW YORK (GenomeWeb News) - Geron and Exeter Life Sciences said today that Start Licensing, a joint venture between the two firms, and ViaGen, a subsidiary of Exeter, have merged to form a new entity that will focus on animal cloning.
Start manages and licenses a portfolio of intellectual property rights related to animal reproductive technologies, including nuclear transfer cloning technology that was developed at the Roslin Foundation to clone Dolly the sheep. ViaGen is an animal genomics and livestock cloning firm.
Geron and Exeter said that the merger of the firms combines the "full breadth" of Start's nuclear transfer cloning IP with ViaGen's in-house breeding services and expertise in advanced reproductive technologies, including cloning, "to provide a one-stop licensing and operating company" for animal cloning.
"We believe it makes sound business sense to join a patent estate for nuclear transfer that has been tested and is recognized as dominant with a leading operating company in the field," said David Greenwood, Geron's executive vice president and CFO, in a statement.
Jonathan Thatcher, Exeter Life Science's CEO, said that the combined...
Related Articles
By Emma McDonald Kennedy
| 04.24.2025
A Review of Eggonomics: The Global Market in Human Eggs and the Donors Who Supply Them by Diane M. Tober
A recent journalistic investigation of the global egg trade at Bloomberg put the industry’s unregulated practices and their exploitative implications back in the spotlight. Diane Tober’s book Eggonomics: The Global Market in Human Eggs and the Donors Who Supply Them, published in October of last year, delves even more deeply into the industry with a thorough examination of egg...
By Nafeez Ahmed, Byline Times | 04.04.2025
It’s hard to believe, but it’s happening. On 27 March 2025, President Donald Trump issued an Executive Order, ‘Restoring Truth and Sanity to American History’. Among its main concerns was the Smithsonian American Art Museum which, the order complained...
Gray wolf by Jessica Eirich via Unsplash
“I’m not a scarcity guy, I’m an abundance guy”
– Colossal co-founder and CEO Ben Lamm, The New Yorker, 4/14/25
Even the most casual consumers of news will have seen the run of recent headlines featuring the company Colossal Biosciences. On March 4, they announced with great fanfare the world’s first-ever woolly mice, as a first step toward creating a woolly mammoth. Then they topped that on April 7 by unveiling one...
By Katrina Northrop, The Washington Post | 04.06.2025
photo via Wikimedia Commons licensed under CC by 3.0
China's most infamous scientist is attempting a comeback. He Jiankui, who went to jail for three years after claiming he had created the world's first genetically altered babies, says he remains...
